Corvus Pharmaceuticals
CRVS
#7819
Rank
A$0.39 B
Marketcap
$5.75
Share price
0.41%
Change (1 day)
147.45%
Change (1 year)

Earnings for Corvus Pharmaceuticals (CRVS)

Earnings in 2024 (TTM): -A$92.72 Million

According to Corvus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$42.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corvus Pharmaceuticals from 2015 to 2024

Annual earnings

Year Earnings Change
2024 -A$97.49 Million130.47%
2023 -A$42.3 Million-34.57%
2022 -A$64.65 Million-4.47%
2021 -A$67.67 Million621.28%
2020 -A$9.39 Million-87.16%
2019 -A$73.04 Million-0.57%
2018 -A$73.46 Million-15.67%
2017 -A$87.11 Million53.03%
2016 -A$56.93 Million16.08%
2015 -A$49.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.23 Billion 129.39%๐Ÿ‡บ๐Ÿ‡ธ USA